Exploring the in-vitro evaluation of folic acid-modified gadolinium nanoparticles in HEK-293, HeLa, and KB cancer cells for targeted-MR-imaging agent candidate.

Fauzia RP, Rahmani AA, Amalia R, Haryuni RD, Irkham I, Bahti HH, Wyantuti S

Open source

DOI
10.1038/s41598-026-38700-7
Published
2026 Aug 7
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-026-38700-7,
  title = {Exploring the in-vitro evaluation of folic acid-modified gadolinium nanoparticles in HEK-293, HeLa, and KB cancer cells for targeted-MR-imaging agent candidate.},
  author = {Fauzia RP and Rahmani AA and Amalia R and Haryuni RD and Irkham I and Bahti HH and Wyantuti S},
  year = {2026},
  journal = {Scientific reports},
  doi = {10.1038/s41598-026-38700-7},
  url = {https://doi.org/10.1038/s41598-026-38700-7}
}

RIS

TY  - JOUR
TI  - Exploring the in-vitro evaluation of folic acid-modified gadolinium nanoparticles in HEK-293, HeLa, and KB cancer cells for targeted-MR-imaging agent candidate.
AU  - Fauzia RP
AU  - Rahmani AA
AU  - Amalia R
AU  - Haryuni RD
AU  - Irkham I
AU  - Bahti HH
AU  - Wyantuti S
PY  - 2026
JO  - Scientific reports
DO  - 10.1038/s41598-026-38700-7
UR  - https://doi.org/10.1038/s41598-026-38700-7
ER  - 

APA

RP, F., AA, R., R, A., RD, H., I, I., HH, B., & S, W. (2026). Exploring the in-vitro evaluation of folic acid-modified gadolinium nanoparticles in HEK-293, HeLa, and KB cancer cells for targeted-MR-imaging agent candidate.. Scientific reports. https://doi.org/10.1038/s41598-026-38700-7

Source records